Actress Hayden Panettiere’s death is followed by resurfaced reports and social media discussion alleging that Neutrogena ended its long-running beauty partnership with her. Two outlets say the contract termination occurred after she publicly discussed her struggles with postpartum depression in the months before her death. Neutrogena is described as dropping her after roughly a decade as an associated brand spokesperson.
The Independent reports that Panettiere faced renewed scrutiny “again” over the claim, referencing comments she made about mental health on live TV and the brand’s subsequent decision. Times of India likewise links the reported end of the deal to her public disclosures about postpartum depression, and notes that her candid talk about motherhood drew significant online attention. Both accounts frame the issue around how public statements about mental health can affect professional relationships, though the reports differ mainly in emphasis and phrasing rather than the core allegation.
The reports describe a cause-and-effect claim, but do not provide detailed documentary evidence in the excerpts provided. The central point across outlets is the allegation that Neutrogena’s decision followed Panettiere’s postpartum depression disclosures.
